These findings highlight the miR-409-3p/SOD1/SETDB1 axis as a critical mechanism in NSCLC and suggest that SOD1 could serve as a promising therapeutic target for treating this malignancy [127]. The gene discussed is SOD1; the disease is non-small cell lung carcinoma.